Delenex preclinical data

In a mouse model of Kaposi’s sarcoma, intraperitoneal 15 mg/kg DLX1008 given 5 days per week for 3 weeks significantly reduced tumor growth vs. an unrelated control single-chain antibody fragment (p<=...